Literature DB >> 20111880

Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization.

Y Bitterman1, A Laor, S Itzhaki, G Weber.   

Abstract

The purpose of this study was to identify differences in the sensitivity of anatomical sites sampling for methicillin-resistant Staphylococcus aureus (MRSA) colonization related to age, gender, clinical situation, and acquisition source as a base for screening protocols. We used a database that included all MRSA-positive cultures (Carmel Medical Center, 2003-2006) taken from nares, throat, perineum, and infection sites. The study population of 597 patients was divided into: "screening sample" (SS), which were cases of routine screening, and "clinical diagnostic sample" (CDS), which were patients with concurrent MRSA infection. MRSA acquisition sources were classified as internal medicine, surgical, referral patients, or intensive care unit (ICU). CDS patients were older than SS patients (median age 78 vs. 74 years, p = 0.0002), more commonly throat colonized (47.5% vs. 31.8%, p = 0.0001), and colonized in more multiple sites (65.7% vs. 43.3% were colonized in three sites in the CDS and SS groups, respectively, p < 0.001) than SS patients. In the SS, group throat colonization was higher in internal medicine wards than in the ICU (odds ratio [OR] = 3.98, p < 0.0001). In the CDS group, perineal colonization was more common in referral patients than in the ICU (OR = 4.52, p < 0.05). Patient age was the most influential factor on nares and multiple sites colonization in the SS and CDS groups, respectively. Our data support multiple sites sampling. Throat cultures are crucial in MRSA-infected patients and internal medicine ward patients. Multiple body sites colonization is more likely in older or MRSA-infected patients, affecting decisions regarding eradication using topical antibiotics.

Entities:  

Mesh:

Year:  2010        PMID: 20111880     DOI: 10.1007/s10096-009-0869-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

1.  An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital.

Authors:  M S Barakate; Y X Yang; S H Foo; A M Vickery; C A Sharp; L D Fowler; J P Harris; R H West; C Macleod; R A Benn
Journal:  J Hosp Infect       Date:  2000-01       Impact factor: 3.926

2.  Screening for methicillin-resistant Staphylococcus aureus: which anatomical sites to culture?

Authors:  O Meurman; M Routamaa; R Peltonen
Journal:  J Hosp Infect       Date:  2005-10-07       Impact factor: 3.926

3.  Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

Authors:  M A Abramson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-06       Impact factor: 3.254

4.  On the statistical analysis of ROC curves.

Authors:  M L Thompson; W Zucchini
Journal:  Stat Med       Date:  1989-10       Impact factor: 2.373

5.  Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus.

Authors:  M D Sanford; A F Widmer; M J Bale; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

6.  Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.

Authors:  C Chaix; I Durand-Zaleski; C Alberti; C Brun-Buisson
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  The throat: an important site for MRSA colonization.

Authors:  Håkan Ringberg; Ann Cathrine Petersson; Mats Walder; P J Hugo Johansson
Journal:  Scand J Infect Dis       Date:  2006

8.  Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

Authors:  Douglas J Biedenbach; Gary J Moet; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

9.  Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains.

Authors:  M Pujol; C Peña; R Pallares; J Ariza; J Ayats; M A Dominguez; F Gudiol
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

10.  Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection.

Authors:  D R Mest; D H Wong; K J Shimoda; M E Mulligan; S E Wilson
Journal:  Anesth Analg       Date:  1994-04       Impact factor: 5.108

View more
  18 in total

1.  Methicillin-resistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis.

Authors:  Leonard A Mermel; Jennifer M Cartony; Pauline Covington; Gail Maxey; Dan Morse
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

2.  Dual-site sampling improved detection rates for MRSA colonization in patients with cutaneous abscesses.

Authors:  L May; C McCann; G Brooks; R Rothman; L Miller; J Jordan
Journal:  Diagn Microbiol Infect Dis       Date:  2014-05-20       Impact factor: 2.803

3.  Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort.

Authors:  Jason E Farley; Matthew J Hayat; Paul L Sacamano; Tracy Ross; Karen Carroll
Journal:  Am J Infect Control       Date:  2015-02-14       Impact factor: 2.918

4.  Detection of methicillin-resistant Staphylococcus aureus (MRSA) in specimens from various body sites: performance characteristics of the BD GeneOhm MRSA assay, the Xpert MRSA assay, and broth-enriched culture in an area with a low prevalence of MRSA infections.

Authors:  Michael Hombach; Gaby E Pfyffer; Malgorzata Roos; Katja Lucke
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

5.  Evaluation of the impact of direct plating, broth enrichment, and specimen source on recovery and diversity of methicillin-resistant Staphylococcus aureus isolates among HIV-infected outpatients.

Authors:  S K McAllister; V S Albrecht; G E Fosheim; H K Lowery; P J Peters; R Gorwitz; J L Guest; J Hageman; R Mindley; L K McDougal; D Rimland; B Limbago
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

6.  A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.

Authors:  John M Boyce; Olivia-Fabiola Pop; Odaliz Abreu-Lanfranco; Whitney Y Hung; Ann Fisher; Afshin Karjoo; Benjamin Thompson; Zenon Protopapas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

7.  Clonally related methicillin-resistant Staphylococcus aureus isolated from short-finned pilot whales (Globicephala macrorhynchus), human volunteers, and a bayfront cetacean rehabilitation facility.

Authors:  Suzanne Hower; Matthew C Phillips; Micah Brodsky; Adrienne Dameron; Manuel A Tamargo; Norma C Salazar; Charlene R Jackson; John B Barrett; Maureen Davidson; Johnnie Davis; Sampa Mukherjee; Ruth Y Ewing; Maribeth L Gidley; Christopher D Sinigalliano; Lisa Johns; Frank E Johnson; Olufunmilola Adebanjo; Lisa R W Plano
Journal:  Microb Ecol       Date:  2013-03-19       Impact factor: 4.552

8.  Screening the nose, throat and the naso-pharynx for methicillin-resistant Staphylococcus aureus: a pilot study.

Authors:  Joy Uwemedimo; Deirdre Fitzgerald-Hughes; Peter Kinnevey; Anna Shore; David Coleman; Hilary Humphreys; Toney Thomas Poovelikunnel
Journal:  J Infect Prev       Date:  2020-06-13

Review 9.  Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.

Authors:  Sharon Tsay; Alexander Kallen; Brendan R Jackson; Tom M Chiller; Snigdha Vallabhaneni
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

10.  Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility.

Authors:  Massimo Pacilli; Janna L Kerins; Whitney J Clegg; Kelly A Walblay; Hira Adil; Sarah K Kemble; Shannon Xydis; Tristan D McPherson; Michael Y Lin; Mary K Hayden; Mary Carl Froilan; Elizabeth Soda; Angela S Tang; Ann Valley; Kaitlin Forsberg; Paige Gable; Heather Moulton-Meissner; D Joseph Sexton; Kara M Jacobs Slifka; Snigdha Vallabhaneni; Maroya Spalding Walters; Stephanie R Black
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.